Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,128,522
+$79,871 QoQ
Shares Held
8,381
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#2,298
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nexus Investment Management ULC holds $61,054,403 across 9 Drug Manufacturers - General names. JNJ ranks #3 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
251,016 | $31,713,361 | |
| 2 | PFE |
Pfizer Inc
|
1,023,770 | $24,652,381 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
8,381 | $2,128,522 | |
| 4 | LLY |
ELI LILLY & Co
|
769 | $922,361 | |
| 5 | ABBV |
AbbVie Inc.
|
3,456 | $869,667 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,735 | $479,947 | |
| 7 | BIIB |
Biogen Inc.
|
920 | $198,775 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
953 | $54,911 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,128,522 | 8,381 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,048,651 | 8,381 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,951,745 | 9,431 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,748,696 | 9,431 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,425,310 | 9,331 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,547,453 | 9,331 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,233,030 | 8,526 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,381,723 | 8,526 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,246,160 | 8,526 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,324,999 | 8,376 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,203,136 | 7,676 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,195,537 | 7,676 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,436,051 | 8,676 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,344,780 | 8,676 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $1,532,615 | 8,676 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,221,279 | 7,476 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $1,380,317 | 7,776 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $1,218,633 | 6,876 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $1,244,705 | 7,276 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,094,324 | 6,776 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,009,197 | 6,126 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $1,056,113 | 6,426 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,011,323 | 6,426 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $934,370 | 6,276 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $847,436 | 6,026 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $749,014 | 5,712 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||